GATAD2B and breast carcinoma: GATAD2B was detected among those enriched by sWGA and the intensity of enriched GATAD2B was elevated by TMG treatment, verifying that GATAD2B could be directly modified with O-GlcNAc in breast cancer cells (Figure 6A).